Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial
Open Access
- 1 September 2002
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 78 (3) , 520-528
- https://doi.org/10.1016/s0015-0282(02)03250-8
Abstract
No abstract availableKeywords
Funding Information
- Ferring Pharmaceuticals
This publication has 25 references indexed in Scilit:
- Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcomeFertility and Sterility, 2001
- Luteinzing Hormone Activity in Menotropins Optimizes Folliculogenesis and Treatment in Controlled Ovarian StimulationJournal of Clinical Endocrinology & Metabolism, 2001
- Luteinzing Hormone Activity in Menotropins Optimizes Folliculogenesis and Treatment in Controlled Ovarian StimulationJournal of Clinical Endocrinology & Metabolism, 2001
- A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study groupHuman Reproduction, 1998
- Androgens stimulate early stages of follicular growth in the primate ovary.Journal of Clinical Investigation, 1998
- Endocrinology: Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophinHuman Reproduction, 1996
- Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activityHuman Reproduction, 1996
- Developmental potential of embryos produced by in-vitro fertilization from gonadotrophin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormoneHuman Reproduction, 1996
- Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phaseFertility and Sterility, 1993
- Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patientsFertility and Sterility, 1991